ArticleInternational journal of women's health2025
A Rare Case of Actinomycetoma In Pregnancy: Effective Treatment with the Combination of Amoxicillin-Clavulanic Acid.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oral amoxicillin-clavulanate: an alternative treatment to refractoryASM case reports · 2026Article
- Diagnosis and Management of a Long-Standing Eumycetoma of the Wrist in Somalia: A Case Report in a Resource-Limited Setting.International medical case reports journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Actinomycetoma is a chronic granulomatous of the skin and subcutaneous tissue caused by filamentous bacterial infection. In pregnancy, this disease is associated with poor clinical outcomes and often unresponsive to standard therapy. Although actinomycetoma is primarily treated with antibiotics, nevertheless, many recommended antibiotics cannot be used during pregnancy due to the potential for fetal harm. Report of actinomycetoma in pregnancy are infrequent. The management of mycetoma in pregnancy requires special attention in various aspects, particularly regarding the safety of the mother and fetus. Case Presentation: A 21-year-old pregnant woman, gestational age of 31-32 weeks, presented with tumefaction, multiple nodules, and sinuses that secreting serosanguinolenta exudate on the right knee. The patient was diagnosed as actinomycetoma according to clinical manifestations of tumefaction, sinuses, and the appearance of grain from direct microscopic and histologic examination. Bacterial culture revealed the growth of Conclusion: Actinomycetoma in pregnancy has limitation in the choice of therapy. The combination of amoxicillin-clavulanic acid can be considered as an effective and relatively safe therapy for pregnancy with actinomycetoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.